RFA-AI-20-080: Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)
Internal Deadline: March 19, 2021
LOI: May 4, 2021
External Deadline: June 4, 2021
Award Type: Cooperative Agreement
Estimated Number of Awards: NIAID intends to commit $1.8M in Direct Costs in FY 2022 to fund 1 award, which includes support of the Infrastructure and Opportunity Fund (IOF).
Anticipated Amount: Application budgets are limited to $1,200,000 direct costs per year; and additional $600,000 per year in direct costs will be reserved to support cross-collaborative IOF projects amongst the HIPC program investigators.
Process for Limited Submissions: PIs must submit their application as a Limited Submission through the Office of Research Application Portal: https://research.usc.edu/usc-grants/.
Materials to submit include:
(1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
(2) CV – (5 pages maximum)
Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
Who May Serve as PI: For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
Purpose: The goal of this FOA is to support a Coordinating Center for the Human Immunology Project Consortium (HIPC) program. The HIPC program, supported through a separate FOA, will consist of 5-8 multi-project cooperative agreement (U19) awardees that will measure the diversity and commonalities of human immune responses under a variety of conditions and longitudinally using high-throughput systems immunology approaches coupled with detailed clinical phenotyping in well-characterized human cohorts. The HIPC Coordinating Center supported by this FOA will be responsible for: coordinating cross-HIPC data integration, analysis, and visualization; developing and maintaining a public HIPC website and knowledgebase to support cross-HIPC data analysis and visualization; and fostering collaborations amongst HIPC-funded investigators by managing the HIPC subcommittees and an Infrastructure and Opportunity Fund to support collaborative studies.
Visit our Institutionally Limited Submission webpage for more updates and other announcements.